Organization | Global Hospital, Hyderabad

Global Hospital, Hyderabad Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial

2006

NCT00408018

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2009

Timeline

NOW

Now

Alternative names

Global Hospital | Global Hospital, Hyderabad, India. | Global Hospitals, Lakdi-ka-pool, Hyderabad - 500 004 India

Active Ingredients

Drugs in Phase 2 Trials (5)

gemcitabine (gemzar) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

peginterferon lambda-1a (1 trial)

ribavirin (virazole) (1 trial)

riviciclib (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 3
# of Trial APIs: 5